Background-Intravascular ultrasound detects stent edge dissections after percutaneous coronary intervention that are not seen angiographically. This study investigated the association between stent edge dissections and clinical outcomes. Methods and Results-ADAPT-DES (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents) was a largescale, prospective, multicenter study of patients undergoing drug-eluting stent implantation. In this prospective substudy, 2062 patients (2433 lesions) were evaluated with intravascular ultrasound to characterize the morphological features and clinical outcomes of stent edge dissection after percutaneous coronary intervention. The prevalence of post-percutaneous coronary intervention stent edge dissection was 6.6% per lesion (161 of 2433). Calcified plaque at the proximal stent edge (relative risk [RR]=1.72; P=0.04) and proximal stent edge expansion (RR=1.18; P=0.004) were predictors for proximal dissection; attenuated plaque at the distal stent edge (RR=3.52; P=0.004), distal reference plaque burden (RR=1.56; P<0.0001), and distal edge stent expansion (RR=1.11; P=0.02) were predictors for distal dissection. At 1-year follow-up, target lesion revascularization was more common in lesions with versus without dissection (5.2% versus 2.7%; P=0.04).
T he main mechanisms of percutaneous coronary intervention (PCI) with stent implantation are vessel expansion and plaque redistribution, 1 and one of the major complications is dissection originating from the proximal or distal stent edge. Although angiographic criteria for a significant dissection have been published, 2 the criteria for a significant intravascular ultrasound (IVUS)-detected stent edge dissection have not been established.
ADAPT-DES (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents) was a large-scale, prospective, multicenter study designed to assess the relationship between platelet reactivity and other clinical and procedural variables and subsequent stent thrombosis and adverse clinical events in patients successfully treated with drug-eluting stents (DES). 3 In a prespecified, prospective IVUS substudy, lesions were evaluated and treated using IVUS-guided PCI. 4 The aims of the current study were to (1) determine the prevalence of stent edge dissection in the contemporary DES era;
(2) evaluate the morphological features of stent edge dissection; (3) clarify outcomes related to untreated stent edge dissections detected by IVUS; and (4) identify criteria for a significant IVUS-detected stent edge dissection that might warrant treatment with additional stent implantation at the time of PCI. IVUS Dissections and Outcomes
Methods

Patient Selection and Imaging
The design, major inclusion, and exclusion criteria, end points, and definitions from the ADAPT-DES study have been described in detail. 3, 4 In brief, ADAPT-DES was a prospective, multicenter, allcomers observational study of 8663 patients who were treated successfully with one or more Food and Drug Administration-or CE (Conformité Européenne) mark-approved DES. There were no major clinical or angiographic exclusion criteria other than the inability to take dual antiplatelet therapy. Procedural IVUS use was per operator discretion; however, the operator was required to report the timing of IVUS imaging and how IVUS information influenced the procedure. Among 2143 patients enrolled in the prespecified IVUS substudy, 2062 patients with 2433 stented lesions including 2215 proximal and 2376 distal adequately imaged reference segments examined by post-PCI IVUS were included in the current analysis.
Angiograms were evaluated visually by operators at the time of the procedure using conventional definitions. 5 Angiographic findings included lesion location and length, reference vessel diameter, preand post-PCI lesion stenosis, thrombolysis in myocardial infarction flow grade, and presence of stent edge dissection.
Clinical follow-up was performed at 30 days and 1 and 2 years. The study was approved by the institutional review board at each participating center, and all eligible patients signed written informed consent. Second-generation DES was defined as everolimus-eluting or slow-release zotarolimus-eluting stents. Stent thrombosis was defined according to the Academic Research Consortium criteria. 6 All-cause and cardiac mortality, myocardial infarction, and stent thrombosis were adjudicated by an independent clinical events committee. A major adverse cardiac event was defined as cardiac death, myocardial infarction, clinically driven target lesion revascularization (TLR), or definite/probable stent thrombosis.
IVUS Image Acquisition
IVUS poststenting was performed using a synthetic aperture array, 20 MHz, 3.2F catheter (Eagle Eye, Volcano Corporation, Rancho Cordova, CA) after intracoronary nitroglycerin. The IVUS catheter was advanced distal to the lesion and was pulled backed to the aortoostial junction using an R-100 (Volcano Corporation) motorized catheter pullback system (0.5 mm/s). IVUS studies were archived onto DVD. Using computerized planimetry software (echoPlaque; INDEC Systems, Inc, Santa Clara, CA), contouring, data output, and off-line grayscale analyses of all imaged segments were performed at an independent IVUS core laboratory (Cardiovascular Research Foundation, New York, NY) by individuals blinded to clinical events.
IVUS Analysis
Quantitative post-PCI IVUS measurements were assessed every 1 mm of the external elastic membrane, lumen, plaque+media (external elastic membrane minus lumen), stent cross-sectional area (CSA), and plaque burden (plaque+media divided by external elastic membrane). Volumes were calculated using Simpson's rule and reported as normalized volumes (volume divided by analysis length).
A culprit lesion was defined as the lesion that was stented. The slices with the minimum lumen CSA and minimum stent CSA within the treated lesion segment were identified and assessed. Proximal and distal 5-mm-long segments from each stent edge, but before a significant (>1.5 mm in diameter) side branch, were defined as the reference segments. The slice with largest lumen CSA with the smallest plaque burden and the slice with the smallest lumen CSA within each reference segment were identified.
Stent edge dissections were evaluated quantitatively and qualitatively at the proximal and distal reference segments. Effective lumen CSA (lumen CSA minus area behind the dissection flap) at the site of the smallest lumen CSA within the dissection segment, maximum dissection angle, and dissection length were measured ( Figure) . 7 Dissections were classified as follows: (1) intimal dissection, (2) medial dissection, (3) intramural hematoma, and (4) extramedial injury. Intimal dissection was defined as a dissection with a tear limited to the intima. Medial dissection was defined as a dissection that extended
WHAT IS KNOWN
• Stent edge dissection is a procedural complication of percutaneous coronary interventions.
• While angiographic criteria for a significant dissection have been reported, the criteria for a significant intravascular ultrasound-detected stent edge dissection have not been established.
WHAT THE STUDY ADDS
• Vessel overstretching and the presence of large, calcified or attenuated plaques at stent edges are the predictors for stent edge dissection.
• Residual stent edge dissections, especially ones with a smaller lumen area (<5.1 mm 2 ), are associated with target lesion revascularization at 1-year follow-up. into the media. Intramural hematoma was a medial dissection but was distinguished by the appearance of blood accumulation within the medial space. 7 Extramedial injury was defined as a dissection extending beyond the media with blood visible in the perivascular tissue ( Figure) . 8 Calcified plaque was defined as hyperechoic plaque with acoustic shadowing. Attenuated plaque was defined as plaques with >30° ultrasonic attenuation (attenuation of deeper arterial structures) in the absence of bright calcium. 9 Focal or diffuse stent expansion was defined as minimum stent CSA or mean stent CSA divided by the average of the largest proximal and distal reference lumen CSA, respectively. Proximal edge stent expansion was defined as the proximal edge stent CSA divided by the largest lumen CSA at the proximal reference segment. Similarly, distal edge stent expansion was defined as the distal edge stent CSA divided by the largest lumen CSA at the distal reference segment.
Statistical Analysis
Baseline clinical characteristics were analyzed on a patient level, whereas angiographic and IVUS characteristics were analyzed on a lesion level. Categorical variables were compared between groups using the χ 2 statistics or the Fisher exact test as appropriate. Continuous variables were compared between groups using the Wilcoxon ranksum test. Univariable and multivariable Poisson regression analyses identified predictors of proximal and distal edge dissections. First, all IVUS variables were compared by presence of dissection, and those that showed a significant difference were included with secondgeneration stent use in a stepwise model selection procedure (entry/ stay criteria of 0.10). The variables entered into the model selection procedure were proximal or distal edge stent expansion, plaque burden, the presence of calcified plaque at the reference segment, and the presence of attenuated plaque at the reference segment. Time-to-event data were summarized as Kaplan-Meier estimates and were compared between groups with the log-rank test. The variable dissection violated the proportional hazard assumption; therefore, multivariable Poisson regression modeled TLR at 1-year included an offset for the follow-up time. Each model included the presence of dissection along with (1) clinically relevant variables (diabetes mellitus, clinical presentation of acute coronary syndrome); and (2) procedure and imaging variables (total stent length, minimum lumen CSA, and larger plaque burden at proximal or distal reference). Receiver operating characteristic curve analysis was conducted to estimate the optimal cutoff value of IVUS morphological parameters to predict dissection, TLR, and major adverse cardiac event at 1 year. Cutoff values were selected based on the point nearest to (0,1) on the receiver operating characteristic curve. All lesion-level analyses were modeled with clustered robust SEs to account for multiple lesions from the same patient. A P value of <0.05 was considered statistically significant. Statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC).
Results
Among 2062 patients with 2433 stented lesions, including 2215 and 2376 evaluable proximal and distal reference segments, respectively, the prevalence of stent edge dissections that were still visible on the final, postprocedure IVUS and were left untreated was 7.7% per patient (159 of 2062) and 6.6% per lesion (161 of 2433)-3.2% at the proximal stent edge (70 of 2215) and 4.1% at the distal stent edge (97 of 2376). Only 6 lesions had dissections involving both the proximal and distal stent edges. In lesions with dissection, the prevalence of intimal dissection, medial dissection, intramural hematoma, and extramedial injury was 38.5% (62 of 161), 42.2% (68 of 161), 18.0% (29 of 161), and 3.1% (5 of 161), respectively. Including lesions with and without dissection, the overall prevalence of intimal dissection was 2.5%, medial dissection was 2.8%, intramural hematoma was 1.2%, and extramedial injury was 0.2%.
Baseline Clinical and Procedural Characteristics
Comparison of baseline clinical and procedural characteristics between patients and lesions with versus without stent edge dissection are summarized in Table 1 . Vessel diameter and maximal stent or balloon diameter were larger in lesions with dissection. Thrombolysis in myocardial infarction 3 flow was observed in all lesions with dissection at the end of procedure. In 160 lesions with IVUS-detected stent edge dissections, only 5 dissections (3.1%) were detected by angiography; conversely, in 2258 lesions without IVUSdetected stent edge dissection, operator angiographic assessment indicated that 9 (0.4%) had dissections. Using IVUS-detected stent edge dissection as the gold standard, the sensitivity, specificity, and positive and negative predictive values of angiographically detected stent edge dissection were 3.1%, 99.6%, 37.5%, and 93.6%, respectively. Lesions treated with second-generation DES were represented less frequently in the dissection group than in the no-dissection group.
Postprocedure IVUS Findings
Postprocedure IVUS findings are shown in Table 2 . Compared with lesions without proximal edge dissection, lesions with proximal edge dissection had larger normalized lumen and stent volumes. Similar trends were observed between lesions with versus without distal edge dissections. At the smallest lumen CSA site in the proximal reference, plaque burden was significantly greater in lesions with proximal edge dissections than in those without proximal edge dissections. A similar trend was observed at the smallest lumen CSA site in the distal reference.
At the proximal edge of the stent, proximal stent edge expansion was significantly greater in lesions with compared with those without proximal dissections. The presence of calcified plaque was also more frequent in lesions with proximal edge dissections. At the distal edge of the stent, distal stent edge expansion was significantly greater in lesions with distal dissections than in those without distal dissections. Calcified and attenuated plaques were also more common in lesions with distal edge dissections.
Predictors of Stent Edge Dissection
By multivariable Poisson regression, presence of calcified plaque at the proximal edge of the stent (relative risk [RR]=1.72; P=0.04) and greater proximal edge stent expansion (RR=1.18; P=0.004) predicted proximal edge dissection ( Table 3 ). The presence of attenuated plaque at the distal edge of the stent (RR=3.52; P=0.004), greater plaque burden at the distal reference segment (RR=1.56; P<0.0001), and greater distal edge stent expansion (RR=1.11; P=0.02) were independent predictors for distal edge dissection (Table 3) .
By receiver operating characteristic curve analysis, the optimal cutoff value of proximal stent expansion to predict proximal edge dissection was 92.9% with an area under the curve value of 0.60 (95% confidence interval, 0.53-0.68; P=0.008), sensitivity of 54.1%, specificity of 65.4%, positive predictive value (PPV) of 5.8%, negative predictive value (NPV) of 97.3%, and accuracy of 64.9%. The optimal cutoff value of distal stent expansion at the distal reference to predict 
Clinical Outcomes
As shown in 25 ) between lesions with and without TLR. By receiver operating characteristic curve analyses, only the effective lumen CSA at dissection site predicted TLR at 1 year. The optimal cutoff vale of the effective lumen CSA at the dissection site to predict TLR was 5.1 mm 2 with an area under the curve value of 0.73 (95% confidence interval: 0.55-0.90; P=0.05), sensitivity of 66.3%, specificity of 65.8%, PPV of 9.2%, NPV of 97.4%, and accuracy of 65.9%.
Discussion
The major findings of this study were the following: (1) the prevalence of residual stent edge dissections detected by IVUS and left untreated was 6.6% per lesion in this population of PCI patients without major procedural complications; (2) vessel overstretching was an independent procedure-related predictor for stent edge dissection and Values are presented as least square means (95% confidence intervals) or % (number of observation/total number of lesions). CSA indicates cross-sectional area; EEM, external elastic membrane; IVUS, intravascular ultrasound; and MLA, minimum lumen cross-sectional area. IVUS Dissections and Outcomes the presence of large, calcified, or attenuated plaques at the edges of the stent were independent lesion-related predictors for stent edge dissection; (3) residual stent edge dissections, especially ones with a smaller effective lumen CSA, increased the incidence of clinically driven TLR at 1-year follow-up.
Prevalence of Coronary Artery Dissection
In the balloon angioplasty era, angiographic data showed a wide range of dissection frequency from 5% to 58%. 2, [10] [11] [12] [13] [14] [15] [16] In the stent era, one large angiographic study of 4630 lesions treated with DES reported a prevalence of 1.7%. 17 IVUS data showed that the prevalence of coronary artery dissection in lesions treated with balloon angioplasty was >60% 16, 18 compared with 11% to 20% in lesions treated with bare metal stents 19-21 and 7.8% in lesions treated with DES. 22 In addition, the detection rates for coronary dissection varied among imaging modalities. Schroeder et al 16 showed that the prevalence of coronary artery dissection in lesions treated with balloon angioplasty was 58% by angiography versus 66% by IVUS. In the bare metal stent era, Sheris et al 21 reported that the prevalence of coronary artery dissection was 0% by angiography versus 10.7% by IVUS. Hong et al 20 reported 3% by angiography versus 19% by IVUS. In the DES era, Liu et al 22 reported that the prevalence of stent edge dissection was 4.8% by angiography and 7.8% by IVUS. Optical coherence tomography (OCT) may be even more sensitive than IVUS; the prevalence of stent edge dissection has ranged from 19% to 38% 23-26 with Bouma et al 23 showing that the frequency of stent edge dissection detection was 4.8% by IVUS versus 19% by OCT.
Predictors for Coronary Artery Dissection
Angiography data have shown that the predictors of coronary artery dissection after balloon angioplasty were greater balloon-to-artery ratio, the presence of calcium, longer lesion length, and greater number of balloon inflations. 14 Previous IVUS data demonstrated that calcium was a predictor for coronary artery dissection after balloon angioplasty. 18 Similarly, angiography data showed that stent edge dissections were more common in longer and calcified lesions 17 ; IVUS data demonstrated that plaque burden at the stent reference segments was significantly greater in lesions with versus without dissections. 19, 20, 22 Liu et al 22 reported that calcium at the proximal edge of the stent was more frequently observed in lesions with versus without proximal edge dissection. The current IVUS study confirms that the presence of calcified plaque at the edge of a stent was an important predictor for dissection regardless of the angle of the calcified plaque and suggests that landing zones be selected to avoid calcified and attenuated plaques.
Using OCT, Gonzalo et al 24 reported that the prevalence of distal stent edge dissection was greater when the plaque type at the stent edge was fibrocalcific or lipid rich than when the plaque was fibrous. Chamié et al 26 demonstrated Table 3 *Cardiac death, myocardial infarction, or clinically driven TLR. †Comparison as lesion-level analysis that includes a correction for clustered observations. IVUS Dissections and Outcomes that independent predictors for stent edge dissection were the presence of atherosclerotic plaque, calcification angle, minimum fibrous cap thickness, thin-cap fibroatheroma, and vessel overstretching. Our present IVUS results were concordant with these OCT data.
. Predictors of Proximal and Distal Stent Edge Dissection by Poisson Regression Analysis
Outcomes Related to Untreated Stent Edge Dissections
In the balloon angioplasty era, the acute clinical success rate was only 37.8% in patients with coronary dissection of type C-F. 2 Conversely, non-flow-limiting coronary dissections were associated with a lower rate of restenosis (ie, so-called therapeutic dissections). 15, 16 Data in the stent era have been less consistent. Nishida et al 27 indicated that non-flow-limiting coronary dissections after balloon angioplasty or stent implantation were associated with favorable clinical outcomes when the IVUS area stenosis at the dissection site was <60%. Meanwhile, large-scale angiography studies showed that stent edge dissection detected by angiography was associated with stent thrombosis both early and at midterm follow-up. 17, 28 Xu et al 29 showed that poststenting IVUS findings of stent edge dissection, inflow/ outflow disease, stent malapposition, stent underexpansion, and tissue protrusion were predictors for long-term adverse outcomes. The most recent OCT study with a relatively small number of patients failed to demonstrate the association between stent edge dissection and adverse clinical events. 26 In this large-scale IVUS study, TLR rate at 1-year follow-up was significantly higher in lesions with edge dissection than in those without edge dissection-especially dissections with a smaller effective lumen CSA that had an even higher rate of TLR at 1-year follow-up. Smaller effective lumen CSA (<5.1 mm 2 ) within the segment containing the stent edge dissection may be a reason to implant additional stents.
This study including only patients who underwent PCI without major periprocedural complications (criteria for inclusion in the overall ADAPT-DES study) failed to show association between long-term outcomes and more severe dissection morphologies such as intramural hematoma and extramedial damage, presumably because of the low prevalence of untreated intramural hematoma (1.2%) and extramedial damage (0.2%) in these patients. Maehara et al 30 and Liu et al 22 showed that the prevalence of intramural hematoma after PCI was 6.7% (69 of 1025 lesions) and 2.7% (28 of 1045 lesions), respectively; Maehara et al 8 reported in another IVUS study that the prevalence of extramedial damage after PCI was 0.5% (76 of 15 000 lesions), higher compared with our present results. However, and unlike the current report, these studies included patients with periprocedural events.
Study Limitations
This study had several limitations. First, this was a crosssectional analysis, not a study with serial IVUS data. The decision of whether or not to use IVUS and enroll patients in the ADAPT-DES substudy was left to the operators' discretion as the manner in which IVUS information was used to optimize the DES implantation procedure. Second, angiography data were reported by each site and were not analyzed at an independent core laboratory. Detailed angiographic data such as lesion angulation and tortuosity were not analyzed. Third, the core laboratory only reviewed the final IVUS examination and not IVUS studies before additional stents were implanted to treat edge dissections. The exact prevalence of IVUS-detectable dissections in the ADAPT-DES IVUS substudy is not known. The manner in which large stent sizing by IVUS affected the prevalence of edge dissections is also unknown. Fourth, because of the number of observations, there may be a type I error; and the data should be interpreted with this in mind. The number of dissections was small, and the sample size was underpowered to conclude the optimal cutoff values of dissection angle and dissection length to predict adverse clinical outcomes. In addition, we failed to show any association between residual dissection and periprocedural myocardial infarction/stent thrombosis because ADAPT-DES included only patients with successful PCI and most patients with periprocedural myocardial infarction and intraprocedural stent thrombosis were excluded. Therefore, the current results should be interpreted cautiously. Finally, TLR was site reported and not adjudicated by an independent clinical events committee. Further studies with detailed angiography analyses, core laboratory review of interprocedural IVUS, and blinded IVUS in the angiographic arm are desirable to validate these findings.
Conclusions
The present large-scale data showed that IVUS-detectable coronary artery dissections left untreated occurred after 6.6% of DES implantation procedures in patients without major periprocedural complications. Greater stent expansion and the presence of large calcified and/or attenuated plaques at the edge of the stent were independent predictors for stent edge dissection. Residual stent edge dissection, especially those with smaller effective lumen CSA, affected TLR at 1-year follow-up. 
